| Source NDC Code |
|
Target HCPCS Code |
70114-0440-01
CIMERLI 0.3 MG/0.05 ML VIAL
|
⇄
|
Q5128
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg
|
| Detail Information |
| Relationship Start Date |
04/01/2023 |
| Relationship End Date |
01/31/2027 |
| Number Of Items In Ndc Package |
0.05 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IO |
| Billing Units |
ML |
|
|
|
70114-0440-01
Cimerli
|
⇄
|
Q5128
Inj, cimerli, 0.1 mg
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|